AR014354A1 - Derivados de 3,4,5,6,7,8-hexahidro-pirido (3',4':4,5) tieno[2,3-d]pirimidina 3-sustituidos y su uso para la preparacion de composiciones farmaceuticas. - Google Patents
Derivados de 3,4,5,6,7,8-hexahidro-pirido (3',4':4,5) tieno[2,3-d]pirimidina 3-sustituidos y su uso para la preparacion de composiciones farmaceuticas.Info
- Publication number
- AR014354A1 AR014354A1 ARP980102768A ARP980102768A AR014354A1 AR 014354 A1 AR014354 A1 AR 014354A1 AR P980102768 A ARP980102768 A AR P980102768A AR P980102768 A ARP980102768 A AR P980102768A AR 014354 A1 AR014354 A1 AR 014354A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- alkyl
- atom
- trifluoromethyl
- cyano
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 3
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- -1 trifluoromethoxy, hydroxy Chemical group 0.000 abstract 2
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
- DDWBRNXDKNIQDY-UHFFFAOYSA-N thieno[2,3-d]pyrimidine Chemical class N1=CN=C2SC=CC2=C1 DDWBRNXDKNIQDY-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Derivados de 3,4,5,6,7,8-hexahidro-pirido (3,4:4,5) tieno (2,3-d) pirimidina 3-sustituidos de la formula I: donde R1 significa un átomo de hidrogeno, un grupo C1-4-alquilo, un grupo acetilo, un radical fenilalquilo C1-4 pudiendo el aromático estar sustituido, eventualmente, por halogeno, gruposC1-4-alquilo, trifluorometilo, hidroxi, C1-4-alcoxi, amino, ciano o nitro, o un radical fenilalcanona, pudiendo el grupo fenilo estar sustituido, R2 significaun grupo fenilo, piridilo, pirimidinilo o piracinilo eventualmente mono o disustituido por átomos de halogeno, C1-4-alquilo, trifluorometilo,trifluorometoxi, hidroxi, C1-4-alcoxi, amino, monometilamino, dimetilamino,ciano o nitro, que puede estar anelado con un nucleo benceno,que eventualmente estámono o disustituido por átomos de halogeno, C1-4-alquilo, hidroxi, trifluorometilo, C1-4-alcoxi, amino, ciano o nitro y contiene eventualmente, un átomo denitrogeno o un anillo de cinco o seis miembros que puede contener 1-2 átomos de oxígeno, A significa NH o un átomo de oxígeno, Y es CH2, CH2-CH2,CH2-CH2-CH2 o CH2-CH. Z significa un átomo de nitrogeno, un átomo de carbono o CH, pudiendo el enlace entre Y y Z ser también un doble enlace, y n representala cifra 2, 3 o 4,así como sus sales con ácidos fisiologicamente toleradas. Uso de los compuestos descriptos anteriormente para la obtencion demedicamentos para el tratamiento de depresiones y enfermedades similares. Uso de dichos compuestos como antagonistas de5HT1a y 5HT1B selectivos, donde elantagonismo selectivo de serotonina va acompanado de una inhibicion de seretonina-Reuptake.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19724979A DE19724979A1 (de) | 1997-06-13 | 1997-06-13 | 3-substituierte Pyrido [3,4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR014354A1 true AR014354A1 (es) | 2001-02-28 |
Family
ID=7832351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102768A AR014354A1 (es) | 1997-06-13 | 1998-06-11 | Derivados de 3,4,5,6,7,8-hexahidro-pirido (3',4':4,5) tieno[2,3-d]pirimidina 3-sustituidos y su uso para la preparacion de composiciones farmaceuticas. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6159981A (es) |
| EP (1) | EP1023296B1 (es) |
| JP (1) | JP2002504104A (es) |
| KR (1) | KR20010013698A (es) |
| CN (1) | CN1259954A (es) |
| AR (1) | AR014354A1 (es) |
| AT (1) | ATE256686T1 (es) |
| AU (1) | AU748697B2 (es) |
| BG (1) | BG103921A (es) |
| BR (1) | BR9810008A (es) |
| CA (1) | CA2293440A1 (es) |
| CO (1) | CO4940481A1 (es) |
| DE (2) | DE19724979A1 (es) |
| ES (1) | ES2215312T3 (es) |
| HR (1) | HRP980318A2 (es) |
| HU (1) | HUP0002736A3 (es) |
| ID (1) | ID24045A (es) |
| IL (1) | IL132985A0 (es) |
| MY (1) | MY132993A (es) |
| NO (1) | NO996045D0 (es) |
| NZ (1) | NZ502237A (es) |
| PL (1) | PL337454A1 (es) |
| SK (1) | SK174399A3 (es) |
| TR (1) | TR199903061T2 (es) |
| TW (1) | TW479059B (es) |
| WO (1) | WO1998056793A1 (es) |
| ZA (1) | ZA985120B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19900545A1 (de) | 1999-01-11 | 2000-07-13 | Basf Ag | Verwendung von Pyrimidinderivaten zur Prophylaxe und Therapie der zerebralen Ischämie |
| DE19900673A1 (de) * | 1999-01-11 | 2000-07-13 | Basf Ag | Verwendung von Bindungspartnern für 5-HT5-Rezeptoren zur Behandlung neurodegenerativer und neuropsychiatrischer Störungen |
| DE10031389A1 (de) * | 2000-07-03 | 2002-01-17 | Knoll Ag | Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie |
| DE10259382A1 (de) * | 2002-12-18 | 2004-07-01 | Abbott Gmbh & Co. Kg | 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-4-on-Derivate, ihre Herstellung und Verwendung |
| US8877316B2 (en) * | 2002-12-20 | 2014-11-04 | The Procter & Gamble Company | Cloth-like personal care articles |
| KR20090114439A (ko) | 2007-02-07 | 2009-11-03 | 아스텔라스세이야쿠 가부시키가이샤 | 아실구아니딘 유도체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5001130A (en) * | 1988-02-18 | 1991-03-19 | Bristol-Myers Company | Psychotropic heterobicycloalkylpiperazine derivatives |
| US4835157A (en) * | 1988-03-15 | 1989-05-30 | Ortho Pharmaceutical Corporation | Thieno- and furopyrimidine-2,4-dione piperidine derivatives as serotonin antagonists and alpha adrenergic blocking agents |
| DE19636769A1 (de) * | 1996-09-10 | 1998-03-12 | Basf Ag | 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung |
-
1997
- 1997-06-13 DE DE19724979A patent/DE19724979A1/de not_active Withdrawn
-
1998
- 1998-05-29 JP JP50145999A patent/JP2002504104A/ja active Pending
- 1998-05-29 SK SK1743-99A patent/SK174399A3/sk unknown
- 1998-05-29 CA CA002293440A patent/CA2293440A1/en not_active Abandoned
- 1998-05-29 PL PL98337454A patent/PL337454A1/xx not_active Application Discontinuation
- 1998-05-29 ES ES98936299T patent/ES2215312T3/es not_active Expired - Lifetime
- 1998-05-29 AT AT98936299T patent/ATE256686T1/de not_active IP Right Cessation
- 1998-05-29 KR KR1019997011713A patent/KR20010013698A/ko not_active Withdrawn
- 1998-05-29 CN CN98806104A patent/CN1259954A/zh active Pending
- 1998-05-29 WO PCT/EP1998/003231 patent/WO1998056793A1/de not_active Ceased
- 1998-05-29 ID IDW991495A patent/ID24045A/id unknown
- 1998-05-29 EP EP98936299A patent/EP1023296B1/de not_active Expired - Lifetime
- 1998-05-29 IL IL13298598A patent/IL132985A0/xx unknown
- 1998-05-29 DE DE59810485T patent/DE59810485D1/de not_active Expired - Fee Related
- 1998-05-29 HU HU0002736A patent/HUP0002736A3/hu unknown
- 1998-05-29 AU AU85357/98A patent/AU748697B2/en not_active Ceased
- 1998-05-29 NZ NZ502237A patent/NZ502237A/en unknown
- 1998-05-29 US US09/445,178 patent/US6159981A/en not_active Expired - Lifetime
- 1998-05-29 TR TR1999/03061T patent/TR199903061T2/xx unknown
- 1998-05-29 BR BR9810008-4A patent/BR9810008A/pt not_active IP Right Cessation
- 1998-06-03 TW TW087108721A patent/TW479059B/zh not_active IP Right Cessation
- 1998-06-11 CO CO98033543A patent/CO4940481A1/es unknown
- 1998-06-11 AR ARP980102768A patent/AR014354A1/es not_active Application Discontinuation
- 1998-06-12 ZA ZA9805120A patent/ZA985120B/xx unknown
- 1998-06-12 HR HR19724979.5A patent/HRP980318A2/hr not_active Application Discontinuation
- 1998-06-13 MY MYPI98002644A patent/MY132993A/en unknown
-
1999
- 1999-11-24 BG BG103921A patent/BG103921A/xx unknown
- 1999-12-08 NO NO996045A patent/NO996045D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP980318A2 (en) | 1999-04-30 |
| ZA985120B (en) | 1999-12-13 |
| US6159981A (en) | 2000-12-12 |
| PL337454A1 (en) | 2000-08-14 |
| WO1998056793A1 (de) | 1998-12-17 |
| CN1259954A (zh) | 2000-07-12 |
| SK174399A3 (en) | 2000-05-16 |
| JP2002504104A (ja) | 2002-02-05 |
| MY132993A (en) | 2007-10-31 |
| ID24045A (id) | 2000-07-06 |
| NO996045L (no) | 1999-12-08 |
| HUP0002736A3 (en) | 2001-04-28 |
| ES2215312T3 (es) | 2004-10-01 |
| BG103921A (en) | 2000-07-31 |
| DE59810485D1 (de) | 2004-01-29 |
| NZ502237A (en) | 2001-08-31 |
| EP1023296A1 (de) | 2000-08-02 |
| TR199903061T2 (xx) | 2000-07-21 |
| NO996045D0 (no) | 1999-12-08 |
| AU748697B2 (en) | 2002-06-13 |
| EP1023296B1 (de) | 2003-12-17 |
| CA2293440A1 (en) | 1998-12-17 |
| IL132985A0 (en) | 2001-03-19 |
| AU8535798A (en) | 1998-12-30 |
| TW479059B (en) | 2002-03-11 |
| CO4940481A1 (es) | 2000-07-24 |
| BR9810008A (pt) | 2000-09-19 |
| HUP0002736A2 (hu) | 2001-02-28 |
| KR20010013698A (ko) | 2001-02-26 |
| DE19724979A1 (de) | 1998-12-17 |
| ATE256686T1 (de) | 2004-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR015712A1 (es) | Derivados de 3,4-dihidro-tieno[2,3-d]pirimidina-3-sustituidos y su uso para la preparacion de composiciones farmaceuticas | |
| ES2195785B1 (es) | Nuevos derivados de piridazin-3(2h)-ona. | |
| MXPA05011710A (es) | Derivados de pirimidina con actividad de crf. | |
| ES2058527T3 (es) | Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2157224T3 (es) | Derivados de 5-arilindol y su uso como agonistas de serotonina (5-ht 1). | |
| BR0315959A (pt) | Composto, composição farmacêutica uso do composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso e processo para a preparação do composto | |
| DE69932173D1 (de) | Adenine-derivate | |
| AR033306A1 (es) | Compuestos | |
| HN2003000407A (es) | Nuevos derivados de fluoroglicosisdos aromaticos, medicamentos que contienen estos compuestos y sus usos. | |
| AR028776A1 (es) | Derivados de la pirimidina y su uso para la profilaxis y la terapia de isquemia cerebral | |
| AR009572A1 (es) | Derivados de 3,4,5,6,7,8-hexahidro pirido (4',3':4,5) tieno (2,3-d) pirimidina sustituidos en posicion 3 y su uso | |
| ES2193875B2 (es) | Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos. | |
| BR9909253A (pt) | Derivados de 2-ariletil-(piperidin-4-ilmetil) amina como antagonistas de receptor muscarìnico | |
| AR008291A1 (es) | Derivados de tetrahidroisoquinolina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso para la preparacionde un medicamento. | |
| MX9806171A (es) | Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa. | |
| BRPI0413013A (pt) | composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças | |
| AR028475A1 (es) | Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion. | |
| AR014354A1 (es) | Derivados de 3,4,5,6,7,8-hexahidro-pirido (3',4':4,5) tieno[2,3-d]pirimidina 3-sustituidos y su uso para la preparacion de composiciones farmaceuticas. | |
| AR027335A1 (es) | Compuestos de piperidina-4-sulfonamida, proceso de preparacion de los mismos, y composiciones farmaceuticas que los contienen | |
| AR016594A1 (es) | DERIVADOS DE 3,4,5,7-TETRAHIDRO-PIRROLO[3',4':4,5]TIENO[2,3-d]PIRIMIDINA 3-SUSTITUIDOS Y SU USO PARA LA PREPARACION DE COMPOSICIONES FARMACEUTICAS | |
| PT902684E (pt) | Derivados hexa-hidro-pirido(4,3-b)indolo utilizados como farmacos antipsicoticos | |
| AR015466A1 (es) | Derivados de tetrahidropiridopirimidinona 3-sustituido y su uso | |
| AR050711A1 (es) | Derivados arilsulfonilestilbeno para el tratamiento y/o prevencion de afecciones del sistema nervioso central | |
| ES2175405T3 (es) | Derivados de adenosina. | |
| AR018032A1 (es) | Derivados del indol-aril sustituidos, un procedimiento para su preparacion, composicion farmaceutica que los comprende y el uso de dichos compuestos parala fabricacion de un medicamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |